- Confirm payer participation, reimbursement terms and site-of-care requirements before scheduling patients at a new AIC.
- Establish financial clearance checkpoints for authorizations, drug sourcing and treatment-location requirements.
- Test clinical documentation, charge capture and billing configurations before the first patient visit.
- Monitor early AIC claims through adjudication and payment to identify recurring reimbursement problems.
- Use clear ownership, connected workflows and performance visibility to support sustainable AIC expansion.
For a home infusion therapy (HIT) provider, opening an ambulatory infusion center (AIC) creates opportunities to serve more patients and strengthen referral relationships. It also introduces reimbursement requirements that need to be addressed before treatment begins.
Existing home infusion workflows provide a foundation, but providers should validate how payer participation, authorizations, documentation and billing will work at the new location. These four priorities can help teams prepare for launch and identify issues before they affect a growing number of accounts.
1. Confirm Payer Readiness Before Scheduling Patients
Start by reviewing the payers and therapies expected to account for your initial patient volume. Confirm whether the proposed billing entity and location meet participation requirements, when participation becomes effective and which site-of-care restrictions apply.
An existing home infusion contract should prompt a review of coverage for the new setting. Even high-demand therapies may face contracting, drug sourcing or reimbursement barriers that limit profitability.
Maintain a shared readiness tracker that records participation status, payment terms, authorization requirements and outstanding issues. Assign an owner and target resolution date to each barrier so scheduling, pharmacy and reimbursement teams have a consistent view of which patients can proceed.
This turns payer readiness into a practical launch control, helping teams resolve gaps before they become treatment delays or unpaid claims.
2. Establish Financial Clearance for the New Setting
A patient moving from home infusion to an AIC needs a reimbursement review that reflects the planned treatment location. Confirm that coverage and authorization support the therapy, dose, frequency, approved units and servicing provider details where applicable.
Drug sourcing should be part of that review. Before committing inventory, verify whether the payer permits the center to purchase and bill for the medication or requires another arrangement.
For example, an authorization supporting treatment at home may need to be updated before the patient’s first AIC appointment. A documented clearance checkpoint helps the team catch that issue while there is still time to resolve it.
Make clearance status visible to everyone involved in preparing the visit, with clear ownership and escalation paths for unresolved requirements. Repeat the review when coverage, treatment or location changes.
3. Test Documentation and Charge Capture Before Launch
Before opening, confirm that the clinical record captures the information billing needs for the services you plan to provide, and where administration coding depends on time, accurate documentation matters.
Walk representative encounters through the proposed workflow, including a routine infusion, multiple administrations, a dose change and an interrupted treatment. Follow each scenario from the order through documentation, charge entry and the proposed claim.
During that review, verify that administered quantities translate correctly into billing units, applicable discarded-drug requirements are addressed and claim configuration reflects the new entity, location and payer requirements.
Use the findings to refine documentation templates and handoffs before live patient volume increases. Resolving these gaps during preparation reduces the need to reconstruct encounter details after treatment.
4. Follow the First Claims Through Payment
Use the initial launch period to validate that your reimbursement workflows perform as expected. Review early encounters closely and follow their claims through submission, adjudication and payment, comparing actual reimbursement with the applicable payment terms.
Keep the new center’s performance visible separately from the established home infusion operation. During early reviews, focus on completed treatments awaiting billing, recurring rejections or denials, payment discrepancies and accounts requiring repeated follow-up.
Assign corrective action based on the underlying cause. If an enrollment issue affects one claim, review other potentially affected accounts. If payments consistently differ from expectations, examine the relevant contract terms and billing configuration before more claims follow the same path.
These reviews give teams an opportunity to correct recurring problems while the affected volume is still manageable.
Build Revenue Cycle Readiness Into Your AIC Launch
Preparing an AIC for its first patient requires a clear path from referral to reimbursement. Establishing checkpoints and ownership before opening helps teams resolve outstanding requirements and maintain consistent execution as treatment volume grows.
Prochant brings specialized revenue cycle expertise across HIT, AIS and AICs. That experience helps providers account for the reimbursement differences between delivery models and connect a new location’s workflows with the broader operation. For a HIT provider entering the AIC space, this means applying established revenue cycle discipline while adapting processes to the new setting.
Through Prochant Pulse™, our proprietary technology, workflow management helps teams assign work and track unresolved issues through completion. Performance visibility supports execution by showing where accounts are stalled and where follow-up is needed. Together, these capabilities help providers manage the additional workload of expansion and identify recurring problems that could delay reimbursement.
Planning an AIC expansion? Connect with Prochant to discuss how our infusion expertise and workflow management capabilities can support your new location.
Frequently Asked Questions
What revenue cycle requirements should home infusion providers consider before opening an ambulatory infusion center?
Before opening an ambulatory infusion center (AIC), home infusion providers should verify payer participation, contracting requirements, site-of-care restrictions, prior authorizations, drug sourcing arrangements and billing configurations. Establishing clear financial clearance and documentation workflows before launch helps reduce treatment delays, claim denials and reimbursement issues.
Can an existing home infusion payer contract be used for a new AIC?
An existing home infusion payer contract does not automatically establish coverage or reimbursement for services delivered at a new ambulatory infusion center. Providers should confirm whether the new location and billing entity meet payer participation requirements, whether additional enrollment or contracting is necessary and which site-of-care restrictions apply before scheduling patients.
How is ambulatory infusion center billing different from home infusion billing?
Ambulatory infusion center billing may involve different payer contracts, servicing locations, authorization requirements, drug reimbursement arrangements and administration coding rules than home infusion billing. Providers expanding into AIC services should validate their documentation, charge capture and claim configurations for the new setting to support accurate reimbursement.
What should be included in an AIC financial clearance process?
An AIC financial clearance process should confirm patient eligibility, payer participation, prior authorization, approved therapy and dose, treatment frequency, billing units, servicing provider details and drug sourcing requirements. Clearance status should be documented and visible to scheduling, pharmacy and reimbursement teams, with clear responsibility for resolving outstanding issues before treatment.
How can home infusion providers prevent claim denials and reimbursement delays when launching an AIC?
Home infusion providers can reduce AIC reimbursement delays by testing documentation and billing workflows before launch, confirming payer and authorization requirements, and closely monitoring the first claims through adjudication and payment. Tracking denials, payment discrepancies, unbilled encounters and accounts requiring repeated follow-up helps teams identify and correct recurring issues before patient volume increases.
